| Product Code: ETC5242434 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Suriname aminoglycosides import market saw significant growth in 2024, with the Netherlands and the United Kingdom emerging as top exporting countries. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, while the impressive compound annual growth rate (CAGR) of 22.21% from 2020 to 2024 highlights strong market expansion. Moreover, the growth rate of 8.52% from 2023 to 2024 suggests continued positive momentum in the import of aminoglycosides to Suriname. These trends underscore the increasing demand and opportunities in the aminoglycosides market in the region.

The Aminoglycosides market in Suriname is projected to grow at a stable growth rate of 2.11% by 2027, within the Latin America region led by Brazil, along with other countries like Mexico, Argentina, Colombia and Chile, collectively shaping a dynamic and evolving market environment driven by innovation and increasing adoption of emerging technologies.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Aminoglycosides Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Aminoglycosides Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Aminoglycosides Market - Industry Life Cycle |
3.4 Suriname Aminoglycosides Market - Porter's Five Forces |
3.5 Suriname Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Suriname Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Suriname Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Suriname Aminoglycosides Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Suriname |
4.2.2 Growing awareness about the effectiveness of aminoglycosides in treating infections |
4.2.3 Rising healthcare expenditure and infrastructure development in Suriname |
4.3 Market Restraints |
4.3.1 High cost associated with aminoglycoside drugs |
4.3.2 Potential side effects and toxicity concerns of aminoglycosides |
4.3.3 Regulatory challenges and stringent approval processes for aminoglycoside drugs |
5 Suriname Aminoglycosides Market Trends |
6 Suriname Aminoglycosides Market Segmentations |
6.1 Suriname Aminoglycosides Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Suriname Aminoglycosides Market Revenues & Volume, By Neomycin, 2021-2031F |
6.1.3 Suriname Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021-2031F |
6.1.4 Suriname Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021-2031F |
6.1.5 Suriname Aminoglycosides Market Revenues & Volume, By Amikacin, 2021-2031F |
6.1.6 Suriname Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021-2031F |
6.1.7 Suriname Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021-2031F |
6.1.9 Suriname Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Suriname Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.2 Suriname Aminoglycosides Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Suriname Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021-2031F |
6.2.3 Suriname Aminoglycosides Market Revenues & Volume, By Feed, 2021-2031F |
6.2.4 Suriname Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021-2031F |
6.2.5 Suriname Aminoglycosides Market Revenues & Volume, By Topical, 2021-2031F |
6.2.6 Suriname Aminoglycosides Market Revenues & Volume, By Oral, 2021-2031F |
6.3 Suriname Aminoglycosides Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Suriname Aminoglycosides Market Revenues & Volume, By Veterinary, 2021-2031F |
6.3.3 Suriname Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021-2031F |
6.3.4 Suriname Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021-2031F |
6.3.5 Suriname Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021-2031F |
6.3.6 Suriname Aminoglycosides Market Revenues & Volume, By Other diseases, 2021-2031F |
7 Suriname Aminoglycosides Market Import-Export Trade Statistics |
7.1 Suriname Aminoglycosides Market Export to Major Countries |
7.2 Suriname Aminoglycosides Market Imports from Major Countries |
8 Suriname Aminoglycosides Market Key Performance Indicators |
8.1 Number of healthcare facilities prescribing aminoglycosides in Suriname |
8.2 Rate of adoption of aminoglycoside drugs in the treatment of bacterial infections |
8.3 Patient adherence and compliance to aminoglycoside treatment regimens |
9 Suriname Aminoglycosides Market - Opportunity Assessment |
9.1 Suriname Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Suriname Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Suriname Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Suriname Aminoglycosides Market - Competitive Landscape |
10.1 Suriname Aminoglycosides Market Revenue Share, By Companies, 2024 |
10.2 Suriname Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |